Approval · Notice of Compliance 27500 · 2022
ARTISS: Notice of Compliance 27500
Issued January 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27500
- Date
- January 28, 2022
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Changes to a drug product manufacturing facility and changes to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARTISS | Not yet assigned | — |
Medicinal ingredients
- CALCIUM CHLORIDE 40 MCMOL
- THROMBIN (HUMAN) 4 UNIT per ML
- SEALER PROTEIN (HUMAN) 125 MG per ML
- APROTININ (SYNTHETIC) 3,000 KIU per ML
- CALCIUM CHLORIDE 40 MCMOL per ML